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Research
Of the > 150 potentially waterborne pathogens
[World Health Organization (WHO) 2004],
Cryptosporidium is the most notorious in devel-
oped countries, having been the suspected
etiologic agent of large waterborne disease out-
breaks (Rose et al. 1997; Thompson et al.
2003). The most striking evidence of the sig-
niﬁcance of Cryptosporidium to water authori-
ties is that regulations and guidelines have been
introduced specifically to deal with it. For
example, in response to outbreaks of cryp-
tosporidiosis in 1995 and 1997, new regula-
tions were introduced in England and Wales,
which required testing and reporting against
legally binding targets for Cryptosporidium con-
centrations that could be found in treated
drinking water [Drinking Water Inspectorate
(DWI) 1999]. In the United States, a series
of regulations under the Safe Drinking Water
Act (U.S. Environmental Protection Agency
1998) required the monitoring and removal of
Cryptosporidium in response to a series of
waterborne cryptosporidiosis outbreaks,
including the largest ever recorded, with an
estimated 400,000 cases [MacKenzie et al.
1994; possibly overestimated through self-
reporting bias (Hunter and Syed 2001)]. In
Sydney, Australia, a series of boil water
advisories in 1998 followed high-level Crypto-
sporidium detections in the city’s water supply
(Cox et al. 2003). Although no cases of illness
were associated with the incident, the Australian
water industry responded by voluntarily adopt-
ing externally audited risk management systems
based on hazard analysis and critical control
points (HACCP) (Deere and Davison 1998;
Havelaar 1994). In comparison, England and
Wales have adopted a regulatory approach
requiring water utilities to monitor Crypto-
sporidium in raw and ﬁnished drinking waters
(DWI 1999; McCann 1999).
Risk-based water-quality management.
Since ﬁrst promoted by Stevens et al. (1995),
the value of adopting a risk-based approach to
water-quality management, for both public
health and aesthetic aspects, has prevailed over
the adoption of increased emphasis on end
point testing-based approaches (Davison et al.
2005; WHO 2004). Risk-based water-quality
management principles can be applied to
watershed management (Barry et al. 1998;
Deere 2004). Importantly, the adoption of a
risk-based approach requires a sound scientiﬁc
evidence base (termed validation) for the state-
ments made in relation to the safety of water
(Davison et al. 2005; WHO 2004). Because of
intense focus on Cryptosporidium in water
safety management, the validation of drinking-
water risk management plans requires particu-
lar attention to the assumptions relating to this
pathogen.
The importance of genotyping Crypto-
sporidium oocysts. Cryptosporidium oocysts are
detected at appreciable concentrations, often
103/g and sometimes reaching > 107/g, in the
feces of a wide variety of the wild and domestic
animals (including humans) found in water-
sheds (Cox et al. 2005; Fayer et al. 2000; Ryan
et al. 2005). However, there is evidence that
the public health signiﬁcance of most of these
oocysts is limited because of a broad genetic
diversity within the Cryptosporidium genus
(Xiao et al. 2004). Human sewage and manure
from domestic cattle and sheep are probably
the most important sources of human-infec-
tious Cryptosporidium (Thompson et al. 2003),
with most cryptosporidiosis cases predomi-
nantly being caused by just two (C. hominis
and C. parvum) of the 15 named Crypto-
sporidium species (Xiao et al. 2004) and just a
fraction of the > 30 described genotypes.
However, routine microscopic detection meth-
ods do not discriminate among species, geno-
types, or subtypes (Thomas and Chalmers
2003), leaving water authorities with data indi-
cating Cryptosporidium presence but no indica-
tion of the health signiﬁcance of this ﬁnding.
Several benefits arise from better under-
standing the public health significance of
Cryptosporidium oocysts in watersheds, includ-
ing significant financial implications. First,
interventions within the watershed can be bet-
ter targeted to the most important land-based
sources. Second, interventions downstream of
the watershed can be proportional to the risk.
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A workshop titled “Application of Genotyping Methods to Assess Pathogen Risks from
Cryptosporidium in Drinking Water Catchments” was held at the International Water Association
biennial conference, Marrakech, Morocco, 23 September 2004. The workshop presented and dis-
cussed the findings of an interlaboratory trial that compared methods for genotyping
Cryptosporidium oocysts isolated from feces. The primary goal of the trial and workshop was to
assess the utility of current Cryptosporidium genotyping methods for determining the public
health signiﬁcance of oocysts isolated from feces in potable-water–supply watersheds. An expert
panel of 16 watershed managers, public health practitioners, and molecular parasitologists was
assembled for the workshop. A subordinate goal of the workshop was to educate watershed man-
agement and public health practitioners. An open invitation was extended to all conference dele-
gates to attend the workshop, which drew approximately 50 interested delegates. In this report we
summarize the peer consensus emerging from the workshop. Recommendations on the use of cur-
rent methods by watershed managers and public health practitioners were proposed. Importantly,
all the methods that were reported in the trial were mutually supporting and found to be valuable
and worthy of further utility and development. Where there were choices as to which method to
apply, the small-subunit ribosomal RNA gene was considered to be the optimum genetic locus to
target. The single-strand conformational polymorphism method was considered potentially the
most valuable for discriminating to the subtype level and where a large number of samples were to
be analyzed. A research agenda for protozoan geneticists was proposed to improve the utility of
methods into the future. Standardization of methods and nomenclature was promoted. Key words:
Cryptosporidium, drinking water, genotyping, watersheds. Environ Health Perspect 114:430–434
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(Australia) do not provide a water treatment
intervention to remove or inactivate Crypto-
sporidium oocysts from their better protected
watersheds, relying instead on watershed pro-
tection and large storage reservoirs. However,
these and many similar towns and cities face
continued pressure to spend hundreds of mil-
lions of dollars on implementing additional
water treatment for Cryptosporidium. In other
cases, boil water advisories have been issued
when oocyst numbers from watersheds reached
levels of concern. Therefore, understanding the
public health signiﬁcance of oocysts circulating
within a speciﬁc watershed, its subwatersheds,
and the associated fauna would enable deci-
sions relating to all three areas—watershed
management, water treatment, and emergency
response—to be better targeted and public
money to be most cost effectively appropriated.
There are a number of means of objectively
assessing the public health signiﬁcance of any
particular isolate of Cryptosporidium oocysts.
The most unequivocal approach is to feed
oocysts to human volunteers (Chappell et al.
1999; DuPont et al. 1995; Messner et al.
2001; Okhuysen et al. 1999). However, with
15 accepted species and > 30 genotypes now
described, this approach is considered too
costly and time-consuming to be practically
applied to more than a fraction of that number
as well as having ethical and safety considera-
tions. Furthermore, experimental infection is
not necessarily a good indicator for natural
infectivity, with some animal feeding trials fail-
ing to show infection in animals with parasite
isolates from the same species—for example,
C. andersoni in cattle. Epidemiologic analysis
of the safety of a whole water supply system is
feasible at reasonable cost (Hellard et al. 2001).
However, most of the risk of Cryptosporidium
exposures from water supplies would arise
under extreme event scenarios when, for exam-
ple, a large storm might coincide with a high
level of human-infectious Cryptosporidium
genotype prevalence in a watershed and a
treatment plant failure (Davison et al. 1999;
Stevens et al. 1995). Therefore, earlier warn-
ing than that provided by epidemiologic stud-
ies is desired by water and health authorities.
The approach considered in this report is to
quantify and type oocyst sources in water-
sheds and compare those with isolates from
human patients. The results permit hypothe-
ses to be tested regarding the similarity of
genotypes propagating within watershed hosts
and those propagating within human popula-
tions consuming the water abstracted from
those watersheds.
Molecular genetic methods of discriminat-
ing pathogens to support epidemiologic inves-
tigations can be applied to help assess the
public health signiﬁcance of Cryptosporidium
oocysts in watersheds (Thompson 2000).
There are some difficulties in applying such
techniques to the small numbers of degraded
oocysts, of mixed population, that are isolated
from water samples. Therefore, the focus of
this report and the workshop described is the
analysis of fresh material from human or
animal feces.
Workshop Objectives
An international trial of methodologies and
a workshop were undertaken to compare
currently available methods for genotyping
Cryptosporidium for assessing the health sig-
nificance of oocysts isolated from fecal stool
samples from watersheds. Full technical
details of the trial and the methodologies used
are given in a separate report (Chalmers et al.
2005). The workshop, titled “Application of
Genotyping Methods to Assess Pathogen
Risks from Cryptosporidium in Drinking
Water Catchments,” was held as part of the
International Water Association Biennial
Conference in Marrakech, Morocco, on
23 September 2004. Before the workshop, an
international trial was held in ﬁve laboratories
across three continents to provide an objective
first assessment of some currently available
methods of Cryptosporidium genotyping and
subtyping in terms of their discriminative
ability, ease of use, practicality, robustness,
and repeatability. The isolates used for the
interlaboratory trial were from fecal samples
and were selected on the basis of available case
data to enable epidemiologic information to
be considered when interpreting results. The
primary goal of the workshop was to gain an
international peer consensus on the utility of
these current Cryptosporidium genotyping
methods for determining the public health
significance of oocysts isolated from feces in
watersheds. Additional goals of the workshop
included developing a research agenda, a
consensus on standardization of both nomen-
clature and methodologies, and the technol-
ogy transfer of methods. A total of 16 invited
participants contributed (Appendix 1) to the
workshop, and > 50 delegates were in atten-
dance, many of whom provided very valuable
commentary.
Discussion and Workshop
Results
Comparison of methods tested. Unpassaged
Cryptosporidium oocysts from a total of
42 human, five lamb, and three calf rectal
swab or stool samples were selected from six
epidemiologically and two nonepidemiologi-
cally based collections and DNA extracts were
prepared from each (Table 1). The genotyp-
ing methods considered at the workshop and
during the interlaboratory trial are summa-
rized in Table 2, which includes a simplistic
analysis of their relative utility.
Some limitations were common to all the
methods tested in relation to typing oocysts
recovered from water samples and are not
identiﬁed in Table 2. Watershed managers can
send Cryptosporidium-positive water samples to
Genotyping Cryptosporidium
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Table 1. Sources of oocysts used for the interlaboratory trial.
Source of feces Location Period Epidemiology Notes
22 human cases Adelaide, Australia 2000 and 2001 Sporadic: case control study (Robertson et al. 2002) 3 immediate family pairs
6 human cases and Wales, UK 2003 Outbreak: open farm (CDSC outbreak
3 bottle-fed lambs number 03/197)
2 human cases and Eastern 2003 Outbreak open farm (John Bailey and
1 scouring lamb, England, UK Susanna Williamson, personal communication)
1 asymptomatic lamb and
1 from calf barn efﬂuent
1 human and 2 calves Northeastern 2002 Sporadic: private farm (Paul Duff, personal Human had access to calf pen
England, UK communication)
4 human cases Wales, UK 2002 Outbreak: rural area (Debra Halstead, personal Private water supply and farm visits possible sources
communication)
4 human cases Northeastern 2000 Outbreak: swimming pool (CDSC outbreak
England, UK reference number 00/406)
5 human cases UK Not stated Sporadic Each of these samples were supplied in duplicate to
provide a single-blinded test for assay repeatability
2 human cases UK 2002 Sporadic 1 sample was prepared as a 1:1 mixture for both to
provide a single-blinded test for assay capability to
discriminate mixtures
CDSC, Communicable Disease Surveillance Center.analytical laboratories for genotyping and sub-
typing (Jiang et al. 2005; Ryan et al. 2005;
Xiao et al. 2000, 2001; Zhou et al. 2003).
Such results have proved valuable to water
authorities, preventing unnecessary alarm
where Cryptosporidium oocysts in water sam-
pled from protected watersheds were shown
not to be human pathogenic genotypes (Jiang
et al. 2005; Xiao et al. 2000; 2001). Oocyst
populations isolated from water are often of
mixed genotype (Jiang et al. 2005; Xiao et al.
2000), very low (< 10) in number [necessitat-
ing nested polymerase chain reaction (PCR)
with its higher risk of artifacts], and may have
lost their nucleic acid content, which is in any
case likely to coextract with PCR inhibitors.
Furthermore, all the methods considered used
nuclear DNA as the target for discrimination,
and thus the methods do not necessarily dis-
criminate viable oocysts from those that are
nonviable but are otherwise intact. Finally, it is
difﬁcult and costly to set up the typing meth-
ods in a form where they provide accurate
quantitation of oocyst numbers present (quan-
titative PCR or serial dilution and most proba-
ble number methods). Therefore, in general,
conventional immunofluorescent antibody
oocyst enumeration would need to be under-
taken in support of typing if quantitative data
are required. Despite these limitations, there
was strong agreement from watershed man-
agers and public health practitioners that the
methods were a valuable and important com-
ponent of characterizing the health-risk impli-
cations of Cryptosporidium oocysts present in
the feces of animals in watersheds.
Although it was possible to simplistically
rank the methods based on their relative per-
formance characteristics (Table 2), this was
considered an overly simplistic approach, and
there was consensus that all the methods
described performed very well and yielded
valuable results. Furthermore, the inferences
made from the results of the various methods
were not contradictory. The precise choice of
which method might be the best in any partic-
ular circumstance would depend on the ques-
tion being asked by the practitioner as well as
practical considerations, such the capability
and experience of local laboratories.
Utility of methods. It was noted that, at
the detailed level, the methods would evolve
and improve over time. Therefore, it was
agreed that a ﬁrst point of consensus needed
to be on the preferred genetic locus to target
because this need not change over time.
Agreement now on the optimum or consensus
locus would help future researchers compare
future with past results. In the context of
Cryptosporidium, genotyping refers to differen-
tiation between different species and geno-
types and requires conservative loci such as the
small-subunit ribosomal DNA (SSU rDNA or
SSU rRNA) (GenBank accession no. L16996;
all accession numbers from the GenBank
Database, http://www.psc.edu/general/
software/packages/genbank/genbank.html)
and the 70-kDa heat-shock protein (HSP70)
locus (GenBank accession no. AF221528).
Subtyping involves looking at variation within
a particular species or genotype and requires
much more variable loci such as the hyper-
variable 60-kDa glycoprotein (GP60) gene
(GenBank accession no. AF164489) and
microsatellites.
The genotyping methods currently used
differ with respect to the genetic locus targeted:
the SSU rRNA gene, the HSP70 gene, or the
GP60 gene. All are acceptable, although there
was consensus that the SSU rRNA gene (SSU
rDNA) was the optimum locus for genotyping
for several reasons. The SSU rDNA locus is
repetitive with a copy number of ﬁve, which
improves method sensitivity. The locus has
been the most commonly targeted for phyloge-
netic analyses and has the largest historical
database worldwide. There are genus-speciﬁc
primers that amplify the SSU rDNA gene for
all 15 species and the > 30 genotypes thus far
described, which is of particular relevance to
environmental studies that include wildlife.
For subtyping, the second internal tran-
scribed spacer region of nuclear ribosomal
DNA (ITS-2) (GenBank accession no.
AF015774) was considered the optimum
locus and is thought to be sufﬁciently variable
as well as being present in multiple copy
number (ﬁve).
A locus not targeted in any of the meth-
ods tested, but one that should not be over-
looked and is of value is the Cryptosporidium
oocyst wall protein (COWP) gene (GenBank
accession no. AF266273), which is useful
when there is ample material from which to
extract DNA, a large number of samples are
to be screened, and C. parvum or C. hominis
species are likely to dominate, such as for
clinical isolates.
The relative value of going to the geno-
typing or subtyping level was considered.
There was not a consensus view from the
workshop participants, although it was noted
that genotyping as a first pass might be
adequate in many studies provided there was
sufﬁcient DNA remaining after the genotyp-
ing to perform subtyping where required.
In application, there was consensus that
Cryptosporidium typing methods could be used
in both a reactive and proactive sense. Reactive
analyses would involve responding to cryp-
tosporidiosis outbreaks or Cryptosporidium
oocyst contamination incidents by typing
oocysts from cases and/or contaminated water
samples and comparing results with those from
putative watershed sources. However, there
was concern that such applications are both
untimely in terms of public health protection
and potentially misleading. False-positive con-
clusions could be supported because common-
ality of genotype does not equate to cause and
effect. False negative conclusions could be
supported because, by definition, sampling
captures only a fraction of the whole and may
miss the true watershed source. Despite these
limitations, reactive typing was considered
worthwhile to assist epidemiologists in testing
hypotheses relating to associations between
water exposure and cryptosporidiosis cases.
A systematic and proactive analysis was
endorsed as the higher priority for watershed
managers and public health practitioners by the
workshop participants. The typing methods
would be used to type oocysts isolated from
putative watershed sources and compare results
with oocysts from sporadic human cases of dis-
ease. If possible, an ongoing study should be
performed rather than an ad hoc snapshot.
Over time, an understanding of the epizoology
and epidemiology of oocysts in the human and
animal populations of the watershed would
build up, which could be related to similar data
for those consuming the yielded water and
other typing databases from human cases. The
resulting database could be used in testing
hypotheses relating to the public health signiﬁ-
cance of oocysts in the watershed. However,
typing studies were understood not to be sim-
ple or short-term projects. The temporal and
spatial variability in Cryptosporidium types
within any particular watershed, as well as the
presence of non-C. parvum and non-C. hominis
infections in some clinical cases, imply the need
Ferguson et al.
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Table 2. Multiple criteria analysis comparing the methods considered during the interlaboratory trial and
discussion points from the International Water Association workshop.
Repeatability Discrimination Typeability Detected
Turnaround [duplicates [no. of types [index mixtures Overall
Method [days (rank)] (rank)] (rank)] (rank)] [in trial (rank)] rank
SSCP of nontranscribed 1 (1) 5/5 (1) 8 (1) 0.96 (2) Yes (1) 1
ITS-region of SSU rDNA
SSCP of transcribed region 1 (1) 5/5 (1) 3 (5) 0.93 (3) Yes (1) 2
of SSU rDNA
Sequencing of GP60 DNA 2 (2) 4/5 (2) 7 (2) 0.78 (6) Partial (2) 3
PCR-RFLP of SSU rDNA 4 (3) 5/5 (1) 5 (4) 0.98 (1) Partial (2) 3
Multilocus genotyping at 2 (2) 2/5 (3) 6 (3) 0.90 (5) Partial (2) 4
3 microsatellites
Sequencing of HSP70 4 (3) 5/5 (1) 3 (5) 0.92 (4) No (3) 5
RFLP, restriction fragment length polymorphism.for great care in both the design and interpreta-
tion of water-related Cryptosporidium-typing
projects.
Research priorities. At the practical level,
the participants agreed that improved stan-
dardization in nomenclature combined with
more consistent methodologies would greatly
facilitate the comparison of isolates from differ-
ent geographic areas and help to better estab-
lish the infectivity or virulence of subtypes.
The value of technology transfer between labo-
ratories and other forms of enhanced collabora-
tion between the participants to the trial and
other genetic researchers was endorsed. The
nomenclature applied to Cryptosporidium
phylogeny was rapidly evolving, and it was
acknowledged that this is an area that may
remain imperfect for the foreseeable future.
However, continued efforts to improve consis-
tency were considered worthwhile. An example
of this problem cited at the workshop was that
one of the trial isolates was typed as three dif-
ferent genotype names in GenBank—cervid,
mouﬂon sheep, and lemur—depending on the
reporting laboratory.
Further characterization of the ITS-2
locus for subtyping was considered necessary.
There was an as yet unrejected hypothesis that
some of the variation seen was due to ampliﬁca-
tion of the SSU rDNA B-type subunit gene. Of
the ﬁve copies of the SSU rDNA of C. parvum,
four copies code for type A and one for type B
(this ratio can differ for other species). There
are genetic differences between types A and B
in the regions incorporated into ribosomes as
well as an approximately 9% difference within
the same isolate in the ITS-2 region (Ryan U,
unpublished observations). Therefore, a limita-
tion of the ITS-2 locus is that some intraisolate
variation could be encountered after ampliﬁca-
tion of the B subtype.
Single-strand conformation polymorphism
(SSCP) is a gel-based tool that can be applied
to any locus and was further considered
because of its performance (Chalmers et al.
2005). Further work will evaluate whether all
currently described genotypes can be identi-
fied and differentiated based on the SSCP
analysis of the SSU rDNA and/or ITS-2 loci
and will assess interlaboratory reproducibility
of the method.
There are a number of limitations with
reliably and routinely analyzing environmental
samples, and two areas of research are required
to overcome these. Methodologic preparative
techniques need to be improved to help cap-
ture more oocysts and recover more of their
DNA. In addition, the ability of genotyping
methods to discriminate and identify the geno-
types and subtypes present in mixed popula-
tions of oocysts needs to be improved. The
former area of research was considered a higher
priority because, if required, dilution can be
used to reduce DNA concentrations to the
point where only one genotype or subtype is
present in any aliquot.
Limited studies have found genotype and
subtype sequences to be stable on passage
although more analysis of stability is warranted.
However, because the purpose of the genotyp-
ing is to assess public health signiﬁcance, more
fundamental research that develops an under-
standing of the human-speciﬁc virulence factors
and their relationship to genotype is a higher
priority. It was noted that, for the loci analyzed
thus far, virulence can vary signiﬁcantly for the
same genotype or subtype, and there may turn
out to be a poorer than desired relationship. For
example, the ﬁrst three oocyst isolates used in
human feeding trials were of the same GP60
subtype but had differences of two orders of
magnitude in infectivity as well as leading to
different symptom severities. Another concern
was raised relating to biases that arise because of
Cryptosporidium subtypes that lead to the great-
est symptom severity predominating in the
human-case databases by reporting bias.
However, this was agreed to be a self-selecting
bias that actually helped in setting public health
priorities for watershed management because
the subtypes that cause the most severe
symptoms are of most publication health con-
cern. It was further noted that the use of cell
lines for infectivity assessment had been shown
to be less than perfectly correlated with infectiv-
ity in humans and certainly not related to
symptom severity after infectivity. For example,
Cryptosporidium andersoni can infect commonly
used HCT-8 cell lines but does not appear to
be infectious and pathogenic in humans.
Conclusion
All the methods reported were consistent with
one another and were agreed by the workshop
participants to be acceptable and capable of
genotyping Cryptosporidium oocysts from ani-
mal and human fecal samples. If choices were
to be made as to which method to apply in any
particular circumstance, the SSU rDNA was
considered the optimum locus to target for rea-
sons that included the size of the current data-
base and the availability of primers that would
detect the presence of all known genotypes.
Partly because of the ready availability of
sequencers, the sequencing-based methods were
considered the most generally applicable if dis-
crimination was only required to the genotype
level. However, where a large number of sam-
ples were to be analyzed, the SSCP method had
a possible advantage because of its lower cost
and may become the default genotyping
method where a large number of samples were
to be analyzed. SSCP was also considered the
most promising method for discriminating at
the subtype level. However, speciﬁc hypotheses
relating to a number of the methods, including
SSCP, need to be tested, including questions
regarding their ability to detect all genotypes of
Cryptosporidium and uncertainties relating
to the true source of subtype variation.
Standardization of the typing methods and of
the nomenclature was promoted to increase the
value of the results for watershed managers and
public health practitioners.
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